Oncolys BioPharma (TSE:4588) Long-Term Debt : 円138.88 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Oncolys BioPharma Long-Term Debt?

Oncolys BioPharma's Long-Term Debt for the quarter that ended in Mar. 2024 was 円138.88 Mil.

Oncolys BioPharma's quarterly Long-Term Debt declined from Sep. 2023 (円172.21 Mil) to Dec. 2023 (円161.10 Mil) and declined from Dec. 2023 (円161.10 Mil) to Mar. 2024 (円138.88 Mil).

Oncolys BioPharma's annual Long-Term Debt declined from Dec. 2021 (円255.54 Mil) to Dec. 2022 (円155.54 Mil) but then increased from Dec. 2022 (円155.54 Mil) to Dec. 2023 (円161.10 Mil).

Oncolys BioPharma Long-Term Debt Historical Data

The historical data trend for Oncolys BioPharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolys BioPharma Long-Term Debt Chart

Oncolys BioPharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

388.88

366.65

255.54

155.54

161.10

Oncolys BioPharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															138.88	194.44	172.21	161.10	138.88

Oncolys BioPharma (TSE:4588) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Oncolys BioPharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Oncolys BioPharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolys BioPharma (TSE:4588) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolys BioPharma Inc (TSE:4588) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-1-28 Toranomon, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001

Website

http://www.oncolys.com

Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.

Oncolys BioPharma (TSE:4588) Headlines

No Headlines